Calls Purchased on Allergan, Inc. (AGN)
November 11, 2010 1:40 PM
Shares of Allergan, Inc. (NYSE: AGN) are lower on the session by 0.09%, currently trading at $69.52. The stock has been moving largely higher over the past six months and is currently trading above the 50-day and 200-day moving averages.
Options traders are buying calls on the name today. A short while ago the December $70.00 call was purchased 1,700 times, on the offer, on open interest of only 228 contracts. This signals new positioning on the strike.
Overall call volume is now running at 2.64x the daily average with 88% of all calls traded being purchases on the offer.
Allergan, Inc. is a multi-specialty health care company focused on developing and commercializing pharmaceuticals, biologics and medical devices. It discovers, develops and commercializes pharmaceutical, medical device and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological and other specialty markets.It has two reportable segments: specialty pharmaceuticals and medical devices.
